4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-037538
Director sold 30,000 shares at $0.57 ($17,100)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WHITFIELD ROY A Director | 2023-06-14 | Sale 10b5-1 | −30,000 | $0.57 | $17,100 | 216,250 | D: show line 1 in the form |
| Open-market sales · 30,000 sh · avg $0.57 · $17,100 | |||||||
Loading xslF345X04/doc4.xml…